NCT07013851
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07013851 |
| Title | Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer (NADIA) |
| Acronym | NADIA |
| Recruitment | Not yet recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Grupo Español de Investigación en Cáncer de Ovario |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
CKB BOOST